CME Group reported $6.77B of revenue over the trailing twelve months, +5.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.77B (to Q2 2026). Free cash flow: $4.21B, trailing twelve months to Q2 2026. Operating margin: 65%, trailing twelve months to Q2 2026. EPS: $11.79, trailing twelve months to Q2 2026.

CMECME Group

Financial Services

$280.55+11% 1Y

$280.55

$231.6852 weeks$317.19

Latest close: back above its 200-day averageOct 9, 2026what changed →

CME as reported

CME Group reported $6.77B of revenue over the trailing twelve months, +5.1% on the year before. 10 reported series are charted on this page, each one as filed.

$6.77B

Revenue, trailing twelve months · to Q2 2026 · +5.1% against the twelve months before

Free cash flow: $4.21B
Free cash flow · +2.6% year on year · trailing twelve months to Q2 2026
Operating margin: 65%
Operating margin · trailing twelve months to Q2 2026
EPS: $11.79
EPS · +14% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CME, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.77B	+5.1%	Q2 2026
Net income	$3.05B	n/a	Q3 2023 · 11 quarters behind
EPS	$11.79	+14%	Q2 2026
Operating margin	65%	n/a	Q2 2026
Net margin	57%	n/a	Q3 2023 · 11 quarters behind
ROE	11%	n/a	Q3 2023 · 11 quarters behind
ROA	1.9%	n/a	Q3 2023 · 11 quarters behind
ROIC	13%	n/a	Q4 2025
Free cash flow	$4.21B	+2.6%	Q2 2026
P/E	23.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.